
商家描述
产品评价(0)
Nuwacell® ncMission hMSC Medium是中盛溯源原研的,一种适用于人类间充质干细胞(hMSC)的临床级/药品级培养基。hMSC在本培养基中可以稳定增殖,同时细胞表面因子表达正常、三系分化潜能完备。
优势:
✔ 适用于多种组织来源MSC的培养;
✔ 高细胞扩增率,连续培养到P3获得的细胞量,是市场同类型产品的5倍以上;每代外泌体收集量是市场同类型产品的2倍以上;
✔ 自主化、国产化的原研体系;供货稳定,高性价比;培养的iPSC细胞通过了中国食品药品检定研究院质量复核;iPSC来源功能药物通过了IND默示许可。
文献引用:
A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis
2021. Yongzhi Cui, et al. Bioactive Materials(IF 16.874).
Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3dependent autophagy in ischemic stroke
2020. Yuguo Xia, et al. Stem Cell Research & Therapy(IF 8.079).
Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells
2022. Youkun Bi, et al. Stem Cell Research & Therapy(IF 8.079)
优势:
✔ 适用于多种组织来源MSC的培养;
✔ 高细胞扩增率,连续培养到P3获得的细胞量,是市场同类型产品的5倍以上;每代外泌体收集量是市场同类型产品的2倍以上;
✔ 自主化、国产化的原研体系;供货稳定,高性价比;培养的iPSC细胞通过了中国食品药品检定研究院质量复核;iPSC来源功能药物通过了IND默示许可。
文献引用:
A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis
2021. Yongzhi Cui, et al. Bioactive Materials(IF 16.874).
Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3dependent autophagy in ischemic stroke
2020. Yuguo Xia, et al. Stem Cell Research & Therapy(IF 8.079).
Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells
2022. Youkun Bi, et al. Stem Cell Research & Therapy(IF 8.079)